Distribution Of Brain Metastasis From Lung Cancer

References

• Riihimaki M, Hemminki A, Fallah M, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014;86(1):78–84. doi:10.1016/j.lungcan.2014.07.02025130083
   PubMed Web of Science ®Google Scholar
• Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G. Epidemiology of metastatic brain tumors. Neurosurg Clin N Am. 2011;22(1):1–6. doi:10.1016/j.nec.2010.08.00721109143
   PubMed Web of Science ®Google Scholar
• Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol. 2005;75(1):5–14. doi:10.1007/s11060-004-8093-616215811
   PubMed Web of Science ®Google Scholar
• Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22(14):2865–2872. doi:10.1200/JCO.2004.12.14915254054
   PubMed Web of Science ®Google Scholar
• Soffietti R, Ruda R, Mutani R. Management of brain metastases. J Neurol. 2002;249(10):1357–1369. doi:10.1007/s00415-002-0870-612382150
   PubMed Web of Science ®Google Scholar
• Kotecha R, Gondi V, Ahluwalia MS, Brastianos PK, Mehta MP. Recent advances in managing brain metastasis. F1000Research. 2018;7. doi:10.12688/f1000research.15903.1
   PubMedGoogle Scholar
• Saito EY, Viani GA, Ferrigno R, et al. Whole brain radiation therapy in management of brain metastasis: results and prognostic factors. Radiat Oncol. 2006;1:20. doi:10.1186/1748-717X-1-2016808850
   PubMed Web of Science ®Google Scholar
• Thon N, Kreth FW, Tonn JC. The role of surgery for brain metastases from solid tumors. Handb Clin Neurol. 2018;149:113–121.29307348
   PubMedGoogle Scholar
• Schild SE, Sio TT, Daniels TB, Chun SG, Rades D. Prophylactic cranial irradiation for extensive small-cell lung cancer. J Oncol Pract. 2017;13(11):732–738. doi:10.1200/JOP.2017.02676529125923
   PubMed Web of Science ®Google Scholar
• Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45(7):741–744. doi:10.1001/archneur.1988.005203100470163390029
   PubMedGoogle Scholar
• Kindt GW. The pattern of location of cerebral metastatic tumors. J Neurosurg. 1964;21:54–57. doi:10.3171/jns.1964.21.1.005414110359
   PubMed Web of Science ®Google Scholar
• Ask-Upmark E. Metastatic tumours of the brain and their localization. Acta Med Scand. 1956;154(1):1–9. doi:10.1111/j.0954-6820.1956.tb14295.x13313064
   PubMedGoogle Scholar
• Takano K, Kinoshita M, Takagaki M, et al. Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor. Neuro Oncol. 2016;18(5):716–724. doi:10.1093/neuonc/nov26626519739
   PubMed Web of Science ®Google Scholar
• Kyeong S, Cha YJ, Ahn SG, Suh SH, Son EJ, Ahn SJ. Subtypes of breast cancer show different spatial distributions of brain metastases. PLoS One. 2017;12(11):e0188542. doi:10.1371/journal.pone.018854229155879
   PubMed Web of Science ®Google Scholar
• Ekici K, Temelli O, Dikilitas M, Halil Dursun I, Bozdag Kaplan N, Kekilli E. Survival and prognostic factors in patients with brain metastasis: single center experience. J Buon. 2016;21(4):958–963.27685920
   PubMed Web of Science ®Google Scholar
• Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361(10):947–957. doi:10.1056/NEJMoa081069919692680
   PubMed Web of Science ®Google Scholar
• Rosell R, Carcereny E, Gervais R, et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2012;13(3):239–246.22285168
   PubMed Web of Science ®Google Scholar
• Sequist LV, Yang JC, Yamamoto N, et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J Clin Oncol. 2013;31(27):3327–3334. doi:10.1200/JCO.2012.44.280623816960
   PubMed Web of Science ®Google Scholar
• Wu SG, Rao MY, Zhou J, et al. Distribution of metastatic disease in the brain in relation to the hippocampus: a retrospective single-center analysis of 6064 metastases in 632 patients. Oncotarget. 2015;6(41):44030–44036. doi:10.18632/oncotarget.582826536661
   PubMedGoogle Scholar
• Ribatti D, Mangialardi G, Vacca A. Stephen Paget and the ‘seed and soil’ theory of metastatic dissemination. Clin Exp Med. 2006;6(4):145–149. doi:10.1007/s10238-006-0117-417191105
   PubMed Web of Science ®Google Scholar
• van Laar PJ, Hendrikse J, Golay X, Lu H, van Osch MJP, van der Grond J. In vivo flow territory mapping of major brain feeding arteries. NeuroImage. 2006;29(1):136–144. doi:10.1016/j.neuroimage.2005.07.01116095923
   PubMed Web of Science ®Google Scholar
• Weidle UH, Birzele F, Kollmorgen G, Ruger R. Dissection of the process of brain metastasis reveals targets and mechanisms for molecular-based intervention. Cancer Genomics Proteomics. 2016;13(4):245–258.27365375
   PubMed Web of Science ®Google Scholar
• Hendrikse J, van der Grond J, Lu H, van Zijl PC, Golay X. Flow territory mapping of the cerebral arteries with regional perfusion MRI. Stroke. 2004;35(4):882–887. doi:10.1161/01.STR.0000120312.26163.EC14988567
   PubMed Web of Science ®Google Scholar
• Ge M, Zhuang Y, Zhou X, Huang R, Liang X, Zhan Q. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases. J Neurooncol. 2013;31(27):413–418. doi:10.1007/s11060-017-2590-x
   Google Scholar
• Li B, Sun SZ, Yang M, et al. The correlation between EGFR mutation status and the risk of brain metastasis in patients with lung adenocarcinoma. J Neurooncol. 2015;124(1):79–85. doi:10.1007/s11060-015-1776-326050023
   PubMed Web of Science ®Google Scholar
• Shigematsu H, Gazdar AF. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer. 2006;118(2):257–262. doi:10.1002/(ISSN)1097-021516231326
   PubMed Web of Science ®Google Scholar
• Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362(25):2380–2388. doi:10.1056/NEJMoa090953020573926
   PubMed Web of Science ®Google Scholar